Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M234,869Revenue $M50,370Net Margin (%)18.7Z-Score3.7
Enterprise Value $M33,235EPS $1.4Operating Margin %28.3F-Score5
P/E(ttm))24.6Cash Flow Per Share $0Pre-tax Margin (%)25.1Higher ROA y-yN
Price/Book10.410-y EBITDA Growth Rate %4.7Quick Ratio1.0Cash flow > EarningsY
Price/Sales4.65-y EBITDA Growth Rate %3.8Current Ratio1.4Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %-14.0ROA % (ttm)14.0Higher Current Ratio y-yN
Dividend Yield %3.1Insider Buy (3m)0ROE % (ttm)45.0Less Shares Outstanding y-yY
Payout Ratio %73.0Shares Outstanding M6,798ROI % (ttm)33.6Gross Margin Increase y-yN

Gurus Latest Trades with RHHBY

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RHHBYKen Fisher 2014-12-31 Add0.07%$34.16 - $37.92
($36.33)
$ 34.55-5%Add 49.26%2,823,025
RHHBYKen Fisher 2014-06-30 Reduce-0.07%$35.42 - $38.07
($36.82)
$ 34.55-7%Reduce -49.71%1,813,443
RHHBYKen Fisher 2014-03-31 Add0.07%$18.14 - $38.17
($29.75)
$ 34.5514%Add 99.00%3,606,140
RHHBYTweedy Browne 2013-06-30 Sold Out $28.92 - $32.98
($30.92)
$ 34.5511%Sold Out0
RHHBYKen Fisher 2013-03-31 Add0.12%$25.25 - $29.3
($27.74)
$ 34.5520%Add 634.57%897,861
RHHBYTweedy Browne 2012-09-30 Reduce-0.03%$20.95 - $24.07
($22.41)
$ 34.5535%Reduce -24.31%62,164
RHHBYVanguard Health Care Fund 2012-06-30 Add2.96%$19.47 - $23.14
($21.16)
$ 34.5539%Add 543.36%4,273,977
RHHBYKen Fisher 2012-06-30 Reduce-0.01%$19.47 - $23.14
($21.16)
$ 34.5539%Reduce -24.26%154,713
RHHBYKen Fisher 2012-03-31 Reduce-1.27%$21.55 - $22.17
($20.04)
$ 34.5542%Reduce -98.02%204,276
RHHBYTweedy Browne 2012-03-31 Reduce-0.04%$21.55 - $22.17
($20.04)
$ 34.5542%Reduce -22.19%82,130
RHHBYVanguard Health Care Fund 2011-03-31 Add0.13%$17.125 - $19.47
($18.17)
$ 34.5547%Add 29.16%664,320
RHHBYKen Fisher 2011-03-31 Add0.09%$17.125 - $19.47
($18.17)
$ 34.5547%Add 8.58%12,136,709
RHHBYPRIMECAP Management 2010-09-30 Sold Out $15.935 - $18.085
($17.03)
$ 34.5551%Sold Out0
RHHBYKen Fisher 2010-09-30 Reduce$15.935 - $18.085
($17.03)
$ 34.5551%Reduce -1.45%12,014,064
RHHBYVanguard Health Care Fund 2010-09-30 Reduce$15.935 - $18.085
($17.03)
$ 34.5551%Reduce -87.65%514,320
RHHBYPRIMECAP Management 2010-06-30 Buy $16.55 - $20.975
($18.52)
$ 34.5546%New holding8,560,865
RHHBYVanguard Health Care Fund 2010-06-30 Add$16.55 - $20.975
($18.52)
$ 34.5546%Add 1.22%4,163,977
RHHBYKen Fisher 2010-06-30 Reduce$16.55 - $20.975
($18.52)
$ 34.5546%Reduce -0.10%12,190,670
RHHBYKen Fisher 2009-12-31 Reduce$19.6 - $21.6
($20.4)
$ 34.5541%Reduce -1.11%12,081,879
RHHBYVanguard Health Care Fund 2009-12-31 Add$19.6 - $21.6
($20.4)
$ 34.5541%Add 858.25%4,113,977
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RHHBY is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


RHHBY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about RHHBY :

    Quarterly/Annual Reports about RHHBY:

      News about RHHBY:

      Articles On GuruFocus.com
      What Are The Intrinsic Factors Contributing To Pfizer’s Stock Movement? Mar 27 2015 
      AbbVie To Acquire Biopharmaceutical Firm Pharmacyclics Mar 06 2015 
      Small Cap Biotech Growth Stocks For 2015 Mar 05 2015 
      Can These Three BioTech Companies Make It Big? Feb 20 2015 
      Pharmaceuticals Sector To See High Voltage Action in 2015 Jan 23 2015 
      Roche In Expansion Mode Jan 19 2015 
      Why Organovo is A Safe Buy? Dec 18 2014 
      Is Organovo A Safe Buy? Dec 08 2014 
      The Top 5 European Stocks Held During Q3 Nov 25 2014 
      Tweedy Browne Global Reports its Top Five Picks of Q3 Oct 22 2014 

      More From Other Websites
      12:15 pm Roche Hldg's Genentech announces plans to invest more than $125 mln for the expansion of... Mar 26 2015
      Can Pharma Conquer The Consumer The Way Apple Did? This App Might Help Mar 25 2015
      This Biotech Is A Prime Buyout Candidate Mar 23 2015
      Biogen Idec 'Results Particularly Exciting,' Bernstein Says; Lilly, Roche Get a Boost Mar 20 2015
      Prothena Soars On Parkinson's Drug; Biogen In Focus Mar 19 2015
      Juno Therapeutics' (JUNO) Q4 Loss Wider than Expected - Analyst Blog Mar 19 2015
      Sigma-Aldrich Announces Exclusive Distribution Agreement with Roche Mar 19 2015
      Celldex, Roche Ink Deal to Develop Kidney Cancer Drug - Analyst Blog Mar 18 2015
      What's in Store for Juno Therapeutics this Earnings Season? - Analyst Blog Mar 16 2015
      Will Inovio (INO) Disappoint This Earnings Season Again? - Analyst Blog Mar 13 2015
      Xenon Pharmaceuticals Reports 2014 Financial Results and Provides Corporate Update Mar 12 2015
      Xenon Pharmaceuticals Reports 2014 Financial Results and Provides Corporate Update Mar 12 2015
      The Silver Lining In Big Pharma Layoffs And Site Closures? A Redistribution Of Talent And Resources Mar 12 2015
      In Big Shift, 23andMe Will Invent Drugs Using Customer Data Mar 12 2015
      Puma Biotechnology Up on Neratinib Study Initiation - Analyst Blog Mar 11 2015
      New Report From The NEJM On Clinical Trial Reporting Further Tarnishes Biopharma's Image Mar 11 2015
      AVEO Up on Pipeline News, Q4 Loss Narrower than Expected - Analyst Blog Mar 09 2015
      This Top Cancer-Fighter Is Now A Bargain Mar 09 2015
      Florida eye doctor at center of Menendez probe Mar 06 2015
      Bristol-Myers Hits 14-Year High On Big Cancer News Mar 04 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      Steve.dunfield@google
      ReplySteve.dunfield@google - 1 year ago
      Adjust for split?
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK